ArticleOphthalmology science
Annual Trend of Myopia and High Myopia in Children in Japan: A Nationwide Claims Database Study.
Article in Ophthalmology science. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Nationwide epidemiology of retinitis pigmentosa in Japan, 2011-2020: a population-based cohort study.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026Article
- Epidemiology of macular dystrophy in Japan (2011-2020): a nationwide population-based study.Japanese journal of ophthalmology · 2026Article
- Use of Clinical Pharmacology in Slowing the Myopia Epidemic.Clinical pharmacology and therapeutics · 2026Article
- Distribution and Time Trends of Refractive Errors in Japanese Spectacle Wearers.Investigative ophthalmology & visual science · 2026Article
- Age-Specific Increases in the Prevalence and Treatment Burden of Neovascular Age-Related Macular Degeneration in a Super-Aged Society.Investigative ophthalmology & visual science · 2026Article
- Article
- Potential Negative Feedback between Age and Baseline Axial Length on Axial Elongation in High Myopia.Ophthalmology science · 2026Article
- Perspective of the Pharmaceuticals and Medical Devices Agency on Drug Development for Childhood Myopia.Clinical pharmacology and therapeutics · 2026Review
- Factors associated with the high prevalence of myopia and its decrease-A historical review.Acta ophthalmologica · 2025Review
- Incidence and Clinical Practice of Myopic Macular Neovascularization: A Nationwide Population-Based Cohort Study.Ophthalmology scienceArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To determine the prevalence and annual trend of the number of incident cases of myopia and high myopia in children. Design: A nationwide, comprehensive claims database study. Participants: Of 15 million children aged ≤14 years, those covered by the universal health insurance were included. The validation study of the claims-based definitions of myopia and high myopia was conducted using 14 654 individuals aged ≤14 years recruited from 11 diverse medical facilities. Methods: This study comprises a national claims database analysis and a multicenter validation study. Data from the National Database of Health Insurance Claims and Specific Health Checkups of Japan, which contains the nationwide health insurance claims data, were assessed. All individuals aged ≤14 years were reviewed, and children with existing and new onset of myopia or high myopia between January 2011 and December 2020 were identified. A validation study was conducted by reviewing electric medical records. Main Outcome Measures: Prevalence of myopia as of October 1, 2020, and the annual number of incident cases during 2014 to 2020. Results: According to the 2020 population census, there were 14 955 692 children aged ≤14 years. Among them, 5 498 764 patients had myopia on October 1, 2020, corresponding to a prevalence of 36.8%. The number of incident cases of myopia was highest at 8 years of age, increasing from 853.3 cases/person-year in 2015 to 910.7 cases/person-year in 2020. The prevalence of high myopia increased with age, peaking at 0.46% among children aged 10 to 14 years; the number of incident cases annually increased in 5- to 9-year-olds and 10- to 14-year-olds. In the year 2020, when the coronavirus disease 2019 pandemic occurred, a discontinuous increase in the number of incident cases of myopia was observed in children aged 8 to 11 years, not 12 to 14 years. The overall sensitivity and specificity of the claims-based definition for myopia were 88.5% and 79.2%, respectively, whereas the corresponding values for high myopia were 41.6% and 99.8%. Conclusions: This first comprehensive nationwide study revealed the prevalence and annual incidence trends of myopia and high myopia. These findings complement the results of previous high-quality cohort studies, offering a more comprehensive understanding of myopia trends. Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.